Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment

Lancet. 1991 Sep 21;338(8769):725-6. doi: 10.1016/0140-6736(91)91446-2.

Abstract

To assess whether chronic pulmonary colonisation with Pseudomonas aeruginosa in cystic fibrosis is preventable, 26 patients who had never received anti-pseudomonas chemotherapy were randomly allocated to groups receiving either no anti-pseudomonas chemotherapy or oral ciprofloxacin and aerosol inhalations of colistin twice daily for 3 weeks, whenever Ps aeruginosa was isolated from routine sputum cultures. During the 27 months of the trial, infection with Ps aeruginosa became chronic in significantly fewer treated than untreated subjects (2 [14%] vs 7 [58%]; p less than 0.05) and there were significantly fewer Ps aeruginosa isolates in routine sputum cultures in the treated group (49/214 [23%] vs 64/158 [41%]; p = 0.0006). Thus, chronic colonisation with Ps aeruginosa can be prevented in cystic fibrosis by early institution of anti-pseudomonas chemotherapy.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Child
  • Child, Preschool
  • Chronic Disease
  • Ciprofloxacin / administration & dosage
  • Colistin / administration & dosage
  • Cystic Fibrosis / complications*
  • Drug Therapy, Combination
  • Female
  • Humans
  • Infant
  • Male
  • Pseudomonas Infections / complications
  • Pseudomonas Infections / prevention & control*
  • Pseudomonas aeruginosa / growth & development
  • Sputum / microbiology

Substances

  • Ciprofloxacin
  • Colistin